ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 74 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -99.9% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -83.3% | 2,000 | -50.0% | 0.00% | – |
| Q4 2021 | $6,000 | -25.0% | 4,000 | +20.4% | 0.00% | – |
| Q3 2021 | $8,000 | -20.0% | 3,321 | +56.2% | 0.00% | – |
| Q2 2021 | $10,000 | -41.2% | 2,126 | -6.5% | 0.00% | – |
| Q1 2021 | $17,000 | +70.0% | 2,274 | +2.4% | 0.00% | – |
| Q4 2020 | $10,000 | +25.0% | 2,221 | +4.7% | 0.00% | – |
| Q3 2020 | $8,000 | +700.0% | 2,121 | +1652.9% | 0.00% | – |
| Q2 2020 | $1,000 | -93.8% | 121 | -94.2% | 0.00% | – |
| Q1 2020 | $16,000 | -50.0% | 2,077 | -8.1% | 0.00% | – |
| Q4 2019 | $32,000 | -82.5% | 2,261 | -85.3% | 0.00% | – |
| Q3 2019 | $183,000 | +110.3% | 15,427 | +150.2% | 0.00% | – |
| Q2 2019 | $87,000 | +4250.0% | 6,167 | +4954.9% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 122 | +22.0% | 0.00% | – |
| Q4 2018 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |